Literature DB >> 16554490

Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia.

Wing-Yan Au, Sidney Tam, Bonnie M Fong, Yok-Lam Kwong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16554490     DOI： 10.1182/blood-2005-10-4175

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.

Authors:  John Y Rhee; Douglas Tremblay; Amy M Chan; Martin S Tallman; John Mascarenhas
Journal:  Blood Adv       Date:  2019-06-25

2.  Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.

Authors:  E Lengfelder; F Lo-Coco; L Ades; P Montesinos; D Grimwade; B Kishore; S M Ramadan; M Pagoni; M Breccia; A J G Huerta; A M Nloga; J D González-Sanmiguel; A Schmidt; J-F Lambert; S Lehmann; E Di Bona; B Cassinat; W-K Hofmann; D Görlich; M-C Sauerland; P Fenaux; M Sanz
Journal:  Leukemia       Date:  2015-01-28       Impact factor: 11.528

3.  Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.

Authors:  Tseng-Hsi Lin; Hsing-Chun Kuo; Fen-Pi Chou; Fung-Jou Lu
Journal:  BMC Cancer       Date:  2008-02-25       Impact factor: 4.430

4.  Arsenite induces premature senescence via p53/p21 pathway as a result of DNA damage in human malignant glioblastoma cells.

Authors:  Yasuharu Ninomiya; Xing Cui; Takeshi Yasuda; Bing Wang; Dong Yu; Emiko Sekine-Suzuki; Mitsuru Nenoi
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

5.  Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.

Authors:  Tilmann Bochtler; Stefan Fröhling; Wilko Weichert; Volker Endris; Christian Thiede; Barbara Hutter; Michael Hundemer; Anthony D Ho; Alwin Krämer
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-09

6.  Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.

Authors:  Ching-Chan Lin; Yu-Kai Huang; Chia-Fong Cho; Yu-Sen Lin; Chia-Chien Lo; Ting-Ting Kuo; Guan-Chin Tseng; Wei-Chung Cheng; Wei-Chao Chang; Tzu-Hung Hsiao; Liang-Chuan Lai; Jin-Yuan Shih; Yu-Huei Liu; K S Clifford Chao; Jennifer L Hsu; Pei-Chih Lee; Xian Sun; Mien-Chie Hung; Yuh-Pyng Sher
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.